Related Experiment Video
Updated: Mar 16, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Omitted and unjustified medications in the discharge summary
A Perren1, M Previsdomini, B Cerutti
1Intensive Care Unit, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. andreas.perren@eoc.ch
Background:
Limited information exists in regard to drug omissions and unjustified medications in the hospital discharge summary (DS).
Objective:
To evaluate the incidence and types of drug omissions and unjustified medications in the DS, and to assess their potential impact on patient health.
Methods:
A prospective observational review of the DSs of all patients discharged from our Internal Medicine Department over a 3-month period. Data assessment was made by internists using a structured form.
Results:
Of the 577 evaluated DSs, 66% contained at least one inconsistency accounting for a total of 1012 irregularities. There were 393 drug omissions affecting 251 patients, 32% of which were potentially harmful. Seventeen per cent of all medications (619/3691) were unjustified, affecting 318 patients. The unjustified medication was potentially harmful in 16% of cases, occurred significantly more frequent in women than in men (61% vs 50%; p = 0.008) and increased linearly with the number of drugs prescribed (p<0.001). Drug omission had a twofold higher potential to cause harm than unjustified medication.
Conclusions:
Drug omissions and unjustified medications are frequent, and systemic changes are required to substantially reduce these inconsistencies.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Legal Guidelines for Documentation

